Literature DB >> 20022722

Bilateral occipital cortical dysplasia and white matter T2 hyperintensity with mild non-specific myopathy: two sibling cases.

Tohru Okanishi1, Tatsuya Ishikawa, Satoru Kobayashi, Naoki Ando, Ichizo Nishino, Hajime Togari, Ikuya Nonaka.   

Abstract

We report two heterosexual sibling cases of mild non-specific myopathy, with bilateral occipital cortical dysplasia and diffuse white matter hyperintensity on brain magnetic resonance imaging (MRI). The histological examination of the muscle in the elder sister revealed non-specific myopathic changes and no reductions of alpha-dystroglycan and laminin alpha2 expressions. The characteristic findings in the occipital lobe on brain MRI in both cases suggested cobblestone lissencephaly. Disrupted structure of the glia limitans and pial basement membrane complex, by a cause other than an alpha-dystroglycan and laminin alpha2 abnormality, may be the cause of the cortical dysplasia in the sibling cases. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20022722     DOI: 10.1016/j.braindev.2009.11.006

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  2 in total

1.  Heterozygous deletion of a 2-Mb region including the dystroglycan gene in a patient with mild myopathy, facial hypotonia, oral-motor dyspraxia and white matter abnormalities.

Authors:  Amy R Frost; Sabrina V Böhm; Raj N Sewduth; Dragana Josifova; Caroline Mackie Ogilvie; Louise Izatt; Roland G Roberts
Journal:  Eur J Hum Genet       Date:  2010-03-17       Impact factor: 4.246

2.  Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.

Authors:  Farid Radmanesh; Ahmet Okay Caglayan; Jennifer L Silhavy; Cahide Yilmaz; Vincent Cantagrel; Tarek Omar; Başak Rosti; Hande Kaymakcalan; Stacey Gabriel; Mingfeng Li; Nenad Sestan; Kaya Bilguvar; William B Dobyns; Maha S Zaki; Murat Gunel; Joseph G Gleeson
Journal:  Am J Hum Genet       Date:  2013-03-07       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.